Effects of pituitary adenylate-cyclase-activating polypeptide on the direct-current electroretinogram of the rabbit eye.
Pituitary adenylate-cyclase-activating polypeptide (PACAP) is a recently discovered neuropeptide present in two different forms, PACAP-27 and PACAP-38. Both peptides stimulate the catalytic enzyme adenylate cyclase in pituitary cells. This enzyme is important also regarding the function of the retinal pigment epithelium (RPE). The purpose of the study was to investigate possible influences of PACAP on the rabbit retina and the RPE as reflected in the direct-current (d.c.) electroretinogram (ERG) and the standing potential of the eye (SP). After unilateral sector vitrectomy, a continuous intraocular perfusion with a reference solution alternated with a test solution was established. The corneal d.c. ERG and the SP were recorded from both eyes with the contralateral eye as a control. Both PACAP-27 (0.1 and 1 microM) and PACAP-38 (1 microM) increased the c-wave amplitude significantly (p = 0.028, p = 0.013 and p = 0.024, respectively, n = 4) while neither PACAP-27 (0.1 and 1 microM, p > 0.05, n = 4) nor PACAP-38 (1 microM, p > 0.05, n = 4) produced any significant effects on the a- and b-wave amplitudes of the d.c. ERG. The SP response to the two substances differed with a significant elevation of the SP level with PACAP-27 (1 microM, p = 0.017, n = 4), while PACAP-38 induced a small, nonsignificant SP elevation (1 microM, p > 0.05, n = 4). Retinal penetrations during PACAP-27 (10 microM) perfusion showed an increase in transepithelial potential (TEP) c-wave (p = 0.003) as well as in slow PIII (p = 0.011, n = 3) amplitude level. The results support the presence of PACAP receptors both on the RPE and in the neural retina.
Department of Ophthalmology, Linköping University, Sweden. Sven.Jarkman@eye.liu.se
S
S
Jarkman
M
M
Kato
R
R
Bragadóttir
D000818:Animals; D003315:Cornea / Q000187:drug effects / Q000502:physiology; D004594:Electrophysiology; D004596:Electroretinography; D009479:Neuropeptides / Q000494:pharmacology*; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D011817:Rabbits; D012160:Retina / Q000187:drug effects* / Q000502:physiology; D014821:Vitrectomy
D009479:Neuropeptides; D018377:Neurotransmitter Agents; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide